Hansoh Pharmaceutical Group Co., Ltd. (Hansoh Pharma, 03692.HK), a leading innovation-driven pharmaceutical company in China, and Guangzhou Lupeng Pharmaceutical Co., Ltd. (Lupeng Pharma), which specializes in treatments for malignant tumors…
Bio-Techne’s fourth quarter organic revenue increased by 1% (2% reported) to $306.1 million. For the full year, organic revenue rose by 1% (2% reported) to $1.2 billion. GAAP earnings per…
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), and Medigene AG (FSE: MDG1, Prime Standard) have announced a three-year strategic partnership. The collaboration aims to design…
Royalty Pharma today released its financial results for the second quarter of 2024 and announced an increase in its full-year guidance for Portfolio Receipts. We achieved double-digit growth in Portfolio…
Today, the European Commission (EC) approved ADZYNMA®▼ (recombinant ADAMTS13) for treating ADAMTS13 deficiency in both children and adults with congenital thrombotic thrombocytopenic purpura (cTTP). ADZYNMA is now the first and…
Vertex Announces Reimbursement Agreement with NHS England for CASGEVY™ Vertex has announced a new reimbursement agreement with NHS England, effective immediately, allowing eligible patients with transfusion-dependent beta thalassemia (TDT) to…
Recent findings from the two-part, double-randomized GMMG-HD7 phase 3 study reveal that Sarclisa (isatuximab), combined with lenalidomide, bortezomib, and dexamethasone (RVd), significantly enhances progression-free survival (PFS) in newly diagnosed, transplant-eligible…
Novartis announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Fabhalta® (iptacopan), a first-in-class complement inhibitor designed to reduce proteinuria in adults with primary immunoglobulin…
Eli Lilly today announced its Q2 2024 financial results, highlighting strong performance driven by Mounjaro, Zepbound, and Verzenio, along with significant advancements in global manufacturing. David A. Ricks, Lilly’s chair…
Operating profit rose by 18% in Danish kroner and 19% at constant exchange rates (CER) to DKK 57.8 billion, despite a DKK 5.7 billion impairment loss related to ocedurenone. North…
Rite Aid Announces Flu and RSV Vaccine Appointments Available at All Locations Rite Aid has announced that appointments for both influenza (flu) and respiratory syncytial virus (RSV) vaccines are now…
Professional Pickleball Association (PPA Tour) player James Ignatowich has teamed up with IBSA USA to promote Licart® (diclofenac epolamine) topical system 1.3%. Licart is the only once-a-day topical nonsteroidal anti-inflammatory…